Czech National Bank’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.29M Buy
129,480
+5,358
+4% +$352K 0.05% 312
2026
Q1
$8.84M Buy
124,122
+4,007
+3% +$316K 0.06% 278
2025
Q4
$9.85M Buy
120,115
+4,157
+4% +$324K 0.06% 253
2025
Q3
$8.71M Buy
115,958
+4,035
+4% +$301K 0.06% 266
2025
Q2
$8.29M Buy
111,923
+6,889
+7% +$480K 0.06% 261
2025
Q1
$8.48M Buy
105,034
+5,974
+6% +$513K 0.08% 238
2024
Q4
$7.74M Buy
99,060
+6,034
+6% +$513K 0.07% 244
2024
Q3
$8.73M Buy
93,026
+12,147
+15% +$1.02M 0.09% 212
2024
Q2
$6.3M Buy
80,879
+6,367
+9% +$519K 0.07% 253
2024
Q1
$6.77M Buy
74,512
+5,942
+9% +$494K 0.09% 230
2023
Q4
$5.3M Buy
68,570
+204
+0.3% +$14.3K 0.08% 262
2023
Q3
$4.65M Buy
68,366
+22,207
+48% +$1.62M 0.07% 264
2023
Q2
$3.75M Buy
46,159
+3,384
+8% +$270K 0.09% 239
2023
Q1
$3.51M Buy
+42,775
New +$3.05M 0.09% 247

Other funds holding GEHC

Czech National Bank's GEHC Position: Q2 2026 in Review

Czech National Bank increased its GE HealthCare (GEHC) stake by 4.3% in Q2 2026, buying an estimated $352K and bringing the position to 129,480 shares worth $8.29M. The position accounts for 0.05% of the portfolio, ranked #312.

Czech National Bank first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $9.85M in Q4 2025. 1,228 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Czech National Bank held 129,480 shares of GE HealthCare worth $8.29M as of Q2 2026.
  • Czech National Bank bought 5,358 GE HealthCare shares in Q2 2026, an estimated $352K.
  • GE HealthCare made up 0.05% of Czech National Bank's portfolio in Q2 2026, its #312 holding.
  • Czech National Bank first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Czech National Bank's GE HealthCare position peaked at $9.85M in Q4 2025.
  • 1,228 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Czech National Bank's 13F filing for Q2 2026, filed 8 Jul 2026.